Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages aTyr Pharma Inc. (ATYR) Shareholders To Inquire About Securities Fraud Class Action

Core Points - A securities fraud class action lawsuit has been filed against aTyr Pharma Inc. on behalf of investors who purchased its common stock between January 16, 2025, and September 12, 2025 [1] - Investors have until December 8, 2025, to file a lead plaintiff motion [1] Company Summary - aTyr Pharma Inc. is the subject of a class action lawsuit related to securities fraud, indicating potential legal challenges and implications for the company's stock performance [1]